Login / Signup

Retrospective Study of Acute Kidney Injury Incidence in Patients with Newly Diagnosed Acute Promyelocytic Leukemia.

Tadashi KamioHiroshi KoyamaKiyomitsu FukaguchiShuku SatoWataru KamataSatomi OkadaYotaro Tamai
Published in: Journal of blood medicine (2020)
Incidence of AKI development in patients with newly diagnosed APL during induction chemotherapy was approximately 40%. Moreover, patients who developed AKI tended to be administered vancomycin more frequently. Unnecessary use of vancomycin should be avoided in patients with newly diagnosed APL, and using alternative non-nephrotoxic drugs should be considered for patients at risk of AKI.
Keyphrases
  • newly diagnosed
  • acute kidney injury
  • cardiac surgery
  • risk factors
  • methicillin resistant staphylococcus aureus
  • liver failure
  • drug induced
  • bone marrow
  • respiratory failure